Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline
Ambarish Pandey, Kershaw V. Patel, Wanpen Vongpatanasin, et al.
Circulation (2019) Vol. 140, Iss. 25, pp. 2076-2088
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Diretrizes Brasileiras de Hipertensão Arterial – 2020
Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 116, Iss. 3, pp. 516-658
Open Access | Times Cited: 787
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department
Michael C. Kontos, James A. de Lemos, Steven Deitelzweig, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 20, pp. 1925-1960
Open Access | Times Cited: 125
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 114
Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes
Ambarish Pandey, Muthiah Vaduganathan, Kershaw V. Patel, et al.
JACC Heart Failure (2021) Vol. 9, Iss. 3, pp. 215-223
Open Access | Times Cited: 93
Development and Validation of Machine Learning–Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
Matthew W. Segar, Byron C. Jaeger, Kershaw V. Patel, et al.
Circulation (2021) Vol. 143, Iss. 24, pp. 2370-2383
Open Access | Times Cited: 86
Predicting and preventing heart failure in type 2 diabetes
Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 8, pp. 607-624
Closed Access | Times Cited: 37
Insulin Resistance and Cardiometabolic Risk Profile Among Nondiabetic American Young Adults: Insights From NHANES
Vibhu Parcha, Brittain Heindl, Rajat Kalra, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. e25-e37
Open Access | Times Cited: 54
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
Matthew W. Segar, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 16, pp. 1587-1598
Open Access | Times Cited: 54
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events
Aliza Hussain, Wensheng Sun, Anita Deswal, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 5, pp. 559-571
Open Access | Times Cited: 53
A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings
Inbar Raber, Cian P. McCarthy, James L. Januzzi
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 10, pp. 1357-1367
Open Access | Times Cited: 44
Targeting the ASMase/S1P pathway protects from sortilin-evoked vascular damage in hypertension
Paola Di Pietro, Albino Carrizzo, Eduardo Sommella, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 3
Open Access | Times Cited: 33
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering
Jarett D. Berry, Vijay Nambi, Walter T. Ambrosius, et al.
JAMA Cardiology (2021) Vol. 6, Iss. 12, pp. 1397-1397
Open Access | Times Cited: 34
Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis
E. Stein, William F. Fearon, Sammy Elmariah, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 7
Open Access | Times Cited: 28
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines
Nicholas Marston, Marc P. Bonaca, Petr Jarolı́m, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 11, pp. 1255-1255
Open Access | Times Cited: 37
Validation of the WATCH‐DM and TRS‐HF DM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis
Matthew W. Segar, Kershaw V. Patel, Anne S. Hellkamp, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 20
Plasma S1P (Sphingosine-1-Phosphate) Links to Hypertension and Biomarkers of Inflammation and Cardiovascular Disease: Findings From a Translational Investigation
Amra Jujić, Frank Matthes, Lotte Vanherle, et al.
Hypertension (2021) Vol. 78, Iss. 1, pp. 195-209
Open Access | Times Cited: 25
New strategies and therapies for the prevention of heart failure in high‐risk patients
Michael M Hammond, Ian Everitt, Sadiya S. Khan
Clinical Cardiology (2022) Vol. 45, Iss. S1
Open Access | Times Cited: 17
Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control
Natalie Daya, John W. McEvoy, Robert H. Christenson, et al.
American Journal of Hypertension (2023) Vol. 36, Iss. 11, pp. 602-611
Open Access | Times Cited: 10
Рекомендації Європейського товариства кардіологів ESC 2024 з лікування підвищеного артеріального тиску та гіпертензії
John W. McEvoy, Cian P. McCarthy, Sofie Brouwers, et al.
HYPERTENSION (2025) Vol. 17, Iss. 4, pp. 29-168
Open Access
Systolic and Diastolic Blood Pressure, Cardiac Biomarkers, and Cardiovascular Mortality in Adults Without Cardiovascular Disease
Junchen Guo, Yan Liu, Xiaoxuan Liu, et al.
JACC Advances (2025) Vol. 4, Iss. 5, pp. 101678-101678
Open Access
Continuous positive airway pressure improves blood pressure and serum cardiovascular biomarkers in obstructive sleep apnoea and hypertension
Macy Mei‐Sze Lui, Hung‐Fat Tse, David Lam, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 5, pp. 2003687-2003687
Open Access | Times Cited: 23
Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
Muhammad Shahzeb Khan, Matthew W. Segar, Muhammad Usman, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 7, pp. 825-835
Open Access | Times Cited: 9
High-Sensitivity Troponins in Cardiovascular Disease
Michael C. Kontos, Jeremy Turlington
Current Cardiology Reports (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 21
Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT
Jarett D. Berry, Haiying Chen, Vijay Nambi, et al.
Circulation (2022) Vol. 147, Iss. 4, pp. 310-323
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top